Yongjin Zhou | RF Continuous Glucose Monitor | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Dr. Yongjin Zhou | RF Continuous Glucose Monitor | Best Researcher Award

Shanghai University | China

Prof. Dr. Yong Jin Zhou is a distinguished scholar in electromagnetic fields, microwave technology, and advanced antenna systems. He is currently a Professor in the School of Communication and Information Engineering at Shanghai University, where he has steadily progressed from Assistant to Associate and now full Professor. His academic journey includes a bachelor’s degree in communication engineering from Shandong University and a doctorate in electromagnetic field and microwave technology from Southeast University. He broadened his research experience as a visiting scholar at the University of Houston and gained industry insights as a software engineer at Marvell Technology in Shanghai. Prof. Zhou has authored more than ninety peer-reviewed publications and contributed significantly to the fields of metasurfaces, computational electromagnetism, and novel antennas. His editorial contributions include service on the boards of leading journals, while his international collaborations and conference leadership roles highlight his commitment to advancing global research and academic exchange.

Profile

Scopus

Education

Prof. Dr. Yong Jin Zhou laid the foundation of his academic career with a strong emphasis on communication engineering and applied electromagnetics. He earned his bachelor’s degree in communication engineering from Shandong University, where he developed a solid grounding in wireless systems, signal transmission, and electronic circuit design. His intellectual curiosity and pursuit of advanced knowledge led him to Southeast University, where he undertook doctoral studies in electromagnetic field and microwave technology. His doctoral research was marked by rigorous exploration of microwave theory, computational electromagnetism, and antenna design, forming the bedrock of his later contributions to metasurfaces and smart antenna systems. During his doctoral tenure, he broadened his academic horizons through a visiting scholarship at the University of Houston, which allowed him to engage with international experts and integrate global perspectives into his research. This educational trajectory gave him a rich blend of theoretical mastery and practical exposure, shaping his future as a prolific researcher.

Experience

Prof. Dr. Yong Jin Zhou has a diverse professional background spanning academia, research, and industry. He began his career as a software engineer at Marvell Technology in Shanghai, where he worked on embedded systems and real-world applications of signal processing. He then transitioned to academia, joining Shanghai University as an Assistant Professor in the School of Communication and Information Engineering. Through dedication and impactful research, he was promoted to Associate Professor and later to full Professor, a role in which he continues to lead innovative projects. His experience also includes international exposure as a visiting scholar at the University of Houston, which enriched his academic collaborations and scientific perspective. Over the years, he has published extensively, supervised funded projects, and played key roles as an editor and session chair in international conferences. His blend of industrial and academic expertise has enabled him to bridge theoretical advancements with practical technological applications.

Awards and Honors

Prof. Dr. Yong Jin Zhou has been recognized for his outstanding contributions to the fields of electromagnetics, antennas, and metasurfaces. He holds memberships in prestigious organizations, including IEEE and OSA, and is a Senior Member of the Chinese Institute of Electronics, reflecting his standing in the scientific community. His role as guest editor for the ACES Journal and his service on the editorial boards of the Journal of Electronics & Information Technology and Current Graphene Science highlight his academic leadership and editorial influence. He has been entrusted with chairing technical sessions at several international symposia, showcasing his authority and recognition among peers. His successful acquisition and leadership of national and municipal research funding projects further underline his research excellence and trust within the scientific ecosystem. These honors, along with invitations to contribute to high-impact journals and conferences, demonstrate his international reputation as a leading expert in microwave engineering and metasurface technologies.

Research Focus

Prof. Dr. Yong Jin Zhou’s research is at the forefront of electromagnetic theory and its practical applications, with a primary emphasis on smart metasurfaces, advanced antennas, and computational electromagnetism. His investigations into smart metasurfaces explore their potential to manipulate electromagnetic waves for applications such as shielding, energy harvesting, and wavefront control. He has pioneered innovative antenna designs that enhance communication system performance, offering solutions in bandwidth, miniaturization, and radiation control. His work in computational electromagnetism bridges theoretical models with numerical methods, enabling precise analysis and optimization of complex electromagnetic structures. He also integrates machine learning with electromagnetics to design intelligent sensing systems and next-generation wireless devices. Supported by national and international projects, his research combines fundamental scientific inquiry with practical engineering solutions. His contributions are pushing the boundaries of wave manipulation and sensor technology, aligning with the future demands of communication, sensing, and electronic system innovation.

 

Publications

Title: Smart meta-device powered by stray microwave energies: A green approach to shielding external interference and detection
Year: 2025

Title: Hyperuniform Radiation-Scattering Meta-Device for Scattering Suppression at Grazing-Incidence
Year: 2025

Title: High-resolution Glucose Microwave Sensor Based on Amplified Asymmetric Plasmon Mode
Year: 2025

Title: Machine Learning Assisted Early-Corrosion Detection System for Pipeline Coatings
Year: 2025

Title: Ultra-wideband Planar Magic-T using Interlayer Coupling 3 dB Directional Coupler and Branch-loaded Phase Shifter
Year: 2024

Title: A Miniaturized Pattern-reconfigurable Antenna for Broadband VHF and UHF Communications
Year: 2024

Title: High Precision Multiple Parameter Measurement Sensor Based on Constitutive Parameters Near-Zero Media
Year: 2024

Conclusion

Prof. Dr. Yong Jin Zhou is an accomplished scholar, educator, and researcher whose expertise in metasurfaces, antennas, and computational electromagnetism has advanced both theoretical foundations and real-world applications while establishing him as a respected leader in global scientific communities.

David Canty | Lung Ultrasound | Best Researcher Award

Published on by Cognitive Scientist Awards

Assist. Prof. Dr. David Canty | Lung Ultrasound | Best Researcher Award

University of Melbourne | Australia

Assist. Prof. Dr. David Canty is a world leader in point-of-care ultrasound and a pioneering clinician-scientist in cardiothoracic anaesthesia. He played a transformative role in establishing focused cardiac ultrasound as a disruptive tool in anaesthetic practice and extended its application to multiple medical specialties. His innovative approach combines clinical expertise with cutting-edge educational strategies, introducing simulator-based and eLearning platforms to make ultrasound training scalable, mobile, and self-directed. With more than fifty peer-reviewed publications, numerous grants, and international collaborations, he has advanced both research and clinical practice. Dr. Canty is a respected academic at the University of Melbourne and Monash University, where he has developed award-winning courses and contributed significantly to the integration of ultrasound into medical curricula. His contributions are globally recognized through leadership roles, editorial appointments, and invitations to prestigious conferences, reflecting his commitment to advancing patient care, medical education, and research innovation.

Profile

ORCID

Education

Dr. David Canty pursued his foundational medical training with distinction, earning an MBBS with Honours from the University of Tasmania. His deep interest in perioperative medicine led him to specialist training in anaesthesia at the Royal Melbourne Hospital, culminating in Fellowship of the Australian and New Zealand College of Anaesthetists. He further strengthened his expertise with a Diploma in Perioperative and Critical Care Echocardiography at the University of Melbourne, aligning his clinical interests with advanced imaging technologies. To integrate research into his career, he completed a Doctor of Philosophy at the University of Tasmania, focusing on novel applications of focused cardiac ultrasound in anaesthesia. This academic journey combined rigorous clinical training with advanced scientific inquiry, laying the foundation for his pioneering contributions to ultrasound education and research. His diverse educational milestones shaped his role as both a practicing clinician and an internationally recognized academic leader.

Experience

Dr. Canty’s career spans clinical practice, teaching, research, and leadership. He has served as a specialist anaesthetist across leading hospitals in Australia and internationally, with expertise in adult cardiothoracic and paediatric anaesthesia. His appointments include Monash Health, Epworth Hospital, Cabrini Hospital, and earlier posts at the Royal Melbourne and Royal Hobart Hospitals. Alongside clinical excellence, he has established himself as a leading educator, founding and directing the Focused Ultrasound Simulation Education program. He developed innovative simulation-based courses and integrated ultrasound into the University of Melbourne’s medical curriculum, training doctors, nurses, physiotherapists, and allied health professionals across Australasia and beyond. His academic appointments at the University of Melbourne and Monash University reflect his strong commitment to teaching and mentoring, including supervision of PhD candidates. With leadership roles in national and international anaesthesia and cardiovascular societies, he continues to bridge clinical service with research and education.

Awards and Honors

Dr. Canty’s outstanding contributions to clinical research, education, and innovation have earned him significant recognition nationally and internationally. He was awarded the prestigious MRFF grant to lead a large randomized controlled trial investigating outcomes of focused cardiac ultrasound, reflecting trust in his scientific leadership. His innovative course development at the University of Melbourne earned the Best New Award Course recognition for the Specialist Certificate in Clinical Ultrasound. He has won multiple prizes for oral presentations, including first place at the ANZCA Annual Scientific Meeting and Melbourne Health Research Week, alongside recognition at major international congresses such as the European Association of Cardiothoracic Anaesthesiology. His research outputs have also achieved distinction, with one of his publications recognized as the most cited paper in the journal Anaesthesia. In addition, he serves on editorial boards and professional societies, underscoring the breadth of his influence and the esteem in which he is held.

Research Focus

Dr. Canty’s research focus is centered on advancing the role of point-of-care ultrasound in perioperative and critical care medicine. He pioneered studies on focused cardiac ultrasound and expanded its applications to lung, abdominal, and vascular imaging, significantly influencing patient diagnosis and management. His work evaluates the impact of ultrasound-guided approaches on surgical outcomes, particularly in cardiac surgery and elderly patients undergoing emergency procedures. He has also led the integration of artificial intelligence with ultrasound through collaborations with machine learning experts, aiming to enhance image interpretation and reduce reliance on operator skill. Alongside clinical applications, he has developed a strong stream of educational research, designing simulation-based and eLearning strategies to improve scalability and accessibility of training worldwide. His leadership in large randomized trials and global collaborations underscores his commitment to evidence-based innovation, positioning ultrasound as a transformative tool in modern healthcare.

 

Publications

 

Title: Transesophageal Echocardiography Multimedia Manual
Year: 2025

Title: Preoperative focused echocardiography on patients with fractured neck of femur. ECHONOF-III trial: study protocol for a multicenter randomized controlled trial
Year: 2025

Title: A Pilot Feasibility Study of teaching focused cardiac ultrasound to Australian medical students in a structured program
Year: 2025

Title: Video-Based CSwin Transformer Using Selective Filtering Technique for Interstitial Syndrome Detection
Year: 2025

Title: Convolutional Automatic Identification of B-lines and Interstitial Syndrome in Lung Ultrasound Images Using Pre-Trained Neural Networks with Feature Fusion
Year: 2024

Title: Automatic deep learning-based pleural effusion segmentation in lung ultrasound images
Year: 2023

Conclusion

Dr. David Canty exemplifies the modern clinician-scientist, seamlessly combining clinical excellence, innovative research, transformative education, and international leadership to advance the field of point-of-care ultrasound and improve patient care globally.

Muhammad Saeed | Clinical Research | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Muhammad Saeed | Clinical Research | Best Researcher Award

PRX Research | United States

Dr. Muhammad  Saeed is a highly accomplished physician and clinical research leader with extensive expertise in advancing medical innovation. He has dedicated his career to bridging clinical practice and research, focusing on infectious diseases, chronic illnesses, and novel therapeutics. With a foundation in medicine from Dow Medical College, he progressed to leadership positions in multiple U.S.-based clinical research centers, where he directed diverse clinical trials across infectious diseases, neurology, oncology, cardiology, and respiratory medicine. His contributions extend to both academia and industry, including collaborative work with prestigious global institutions. Dr. Saeed’s scholarly work encompasses book chapters and peer-reviewed publications that highlight his dedication to evidence-based medicine and medical education. Beyond his scientific contributions, he is recognized for mentoring young professionals and promoting ethical research practices. His blend of clinical acumen, research excellence, and leadership has positioned him as a key figure in modern translational research and therapeutic development.

Profile

ORCID

Education

Dr. Muhammad Saeed’s academic journey reflects a commitment to excellence and lifelong learning. He earned his Bachelor of Medicine and Bachelor of Surgery (MBBS) from Dow Medical College, University of Karachi, laying the groundwork for his career in clinical medicine and research. His early training emphasized core competencies in surgery and internal medicine, which provided him with strong clinical insights that continue to inform his research leadership. He later pursued advanced studies at Johns Hopkins University, where he completed a Master of Science, equipping him with rigorous training in epidemiology, clinical trial design, and evidence-based research methodologies. His education also includes formative years at Habib Public School in Karachi, where he achieved GCE O’ Levels under the University of Cambridge Local Examination Syndicate. This broad educational foundation, spanning global institutions of repute, has allowed him to integrate strong clinical skills with research innovation, shaping his role as a physician-scientist and educator.

Experience

Dr. Muhammad Saeed’s professional experience spans diverse roles in clinical medicine and research. He began his medical career as a resident physician at Civil Hospital Karachi, training in surgery and medicine. His early exposure to hospital-based care was complemented by research responsibilities at Aga Khan University Hospital, where he worked as a Clinical Research Associate on infectious diseases and public health projects. Transitioning to the United States, he held leadership positions at Advanced Clinical Research Associates in Plano, HRMD Research in Dallas, and later Dallas Regional Medical Center and PRX Research in Mesquite, where he currently serves as Clinical Research Director. In these roles, he has overseen numerous multicenter, international clinical trials across therapeutic areas including oncology, neurology, cardiology, infectious diseases, and COVID-19. His leadership ensures regulatory compliance, patient safety, and high-quality outcomes in research. This experience highlights his ability to integrate patient care, research innovation, and administrative excellence.

Awards and Honors

Dr. Muhammad Saeed has been recognized for his outstanding contributions to clinical research, academic medicine, and patient-centered healthcare. His work in infectious disease research and clinical trial leadership has earned him respect among peers in both academic and industry settings. He has collaborated with leading researchers globally, resulting in publications and recognition in international medical circles. His co-authored book, What I Wish I Knew Before Medical School, reflects his dedication to mentoring and educating the next generation of healthcare professionals, further enhancing his academic reputation. His chapter contributions to the International Encyclopedia of Public Health positioned him among notable voices in global health. Over his career, he has been acknowledged for his role in advancing therapeutic development, particularly during the COVID-19 pandemic through multiple high-impact trials. These honors reflect not only his scholarly achievements but also his contributions to improving medical care through innovative and ethical clinical research practices

Research Focus

Dr. Muhammad Saeed’s research focus lies at the intersection of clinical innovation and public health. His academic research has addressed infectious diseases, including typhoid detection in children and diabetes risk factors in underserved communities. In industry, he has spearheaded large-scale multicenter clinical trials across diverse therapeutic areas, including cardiology, oncology, neurology, respiratory diseases, and COVID-19. His work emphasizes patient safety, treatment efficacy, and advancing therapeutic options for conditions with high unmet medical needs. He has been deeply involved in clinical trial design, implementation, and analysis, ensuring robust outcomes that translate into better clinical practices. Beyond therapeutic innovation, Dr. Saeed’s work reflects a commitment to advancing methodologies for early disease detection, novel biomarkers, stem-cell based therapies, and cutting-edge treatments for neurodegenerative and chronic illnesses. His research philosophy integrates medical rigor, ethical practice, and translational application, aiming to bring scientific discovery from the research bench directly to patient care with lasting global impact.

 

Publications

Title: Impacts of Ambient Temperatures on Pediatric Anemia in Sub-Saharan Africa: A Regional Ecological Study
Year: 2025

Title: Evaluation of the Potential Of Rejuveinix Plus Dexamethasone Against Sepsis
Year: 2022

Title: Clinical and Non-clinical Proof of Concept Supporting the Development of RJX As an Adjunct to Standard of Care Against Severe COVID-19
Year: 2022

Title: Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis
Year: 2020

Title: Clinical characteristics, management and outcome of major pulmonary embolism: an experience from a tertiary care center in Pakistan
Year: 2009

Conclusion

Dr. Muhammad  Saeed is a distinguished physician-scientist whose career blends clinical expertise, research leadership, and academic scholarship, with a strong focus on advancing therapeutic innovation, improving patient care, and mentoring future medical professionals through global collaborations and ethical research excellence.

Makwena Justice Moloto | Chemistry | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Makwena Justice Moloto | Chemistry | Best Researcher Award

Durban University of Technology | South Africa

Prof. Makwena Justice Moloto is a distinguished South African academic and researcher specializing in nanotechnology, inorganic chemistry, and sustainable water solutions. With a career spanning teaching, research, and leadership roles, he has contributed significantly to advancing scientific knowledge and training future generations of chemists. His professional journey has taken him across leading institutions, where he has held positions from lecturer to full professor, engaging in curriculum development, departmental leadership, and international collaborations. Prof. Moloto has led and participated in various research groups focusing on nanotechnology, catalysis, adsorption, and phytochemistry, producing impactful research outcomes. His work extends beyond national borders through collaborations with universities in Kenya, the United Kingdom, and the United States. He has also served on multiple institutional and national committees, shaping research directions and policies. A prolific researcher and mentor, he continues to drive innovations in nanostructured materials and their applications in health, environment, and sustainability.

Profile

ORCID

Education

Prof. Moloto began his academic journey at the University of Limpopo, where he obtained a Bachelor of Science in Chemistry and Zoology, followed by a Bachelor of Science (Honours) in Chemistry. His passion for research led him to the University of the Western Cape, where he pursued a Master of Science in Chemistry, focusing on organometallic chemistry. He then advanced his studies at the University of Zululand, where he earned his PhD in Inorganic and Nanomaterials Chemistry, a milestone that laid the foundation for his expertise in nanotechnology. His doctoral research was enriched by international research visits to the University of Manchester, where he collaborated under the Royal Society and NRF program, and Jackson State University, where he trained in molecular modelling. Additionally, he complemented his academic achievements with a certificate in Leading and Managing People from Wits Business School, equipping him with leadership skills vital for academic and research management.

Experience

Prof. Moloto’s academic career reflects progressive growth in teaching, research, and leadership across renowned South African universities. He began as a lecturer at the University of Zululand, later serving as Senior Lecturer at institutions such as the University of Witwatersrand and University of Johannesburg, where he taught inorganic, physical, and materials chemistry. His career advanced at the Vaal University of Technology, where he rose to Associate Professor, led departmental research activities, and twice acted as Head of the Chemistry Department. He later served as a Full Professor at the University of South Africa and University of Limpopo, contributing to curriculum development and postgraduate mentorship. Currently, he is a Full Professor at Durban University of Technology, Department of Chemistry, where he supervises postgraduate students, coordinates research, and teaches various chemistry modules. His experience also includes organizing international conferences, serving on research committees, and acting as a reviewer and moderator for multiple institutions.

Awards and Honors

Prof. Moloto’s career is distinguished by numerous awards, honors, and recognitions that highlight his impact on science and education. He has been a recipient of multiple research grants from the National Research Foundation, including Thuthuka and CSUR grants, which supported his pioneering work in nanotechnology and postgraduate supervision. His international collaborations have been facilitated through prestigious programs such as the Royal Society and NRF fellowship, enabling research at the University of Manchester and Jackson State University. He has hosted and mentored several postdoctoral fellows, supported through national and international funding. His leadership in organizing conferences such as NanoAfrica and SACI reflects his role in advancing the global scientific community. Additionally, he has been appointed Chairperson of NRF panels, shaping research funding directions in natural sciences. His contributions to committees, innovation platforms, and academic leadership showcase his commitment to fostering scientific advancement, mentorship, and sustainable innovation in nanotechnology.

Research Focus

Prof. Moloto’s research centers on nanotechnology, inorganic chemistry, and sustainable applications of nanostructured materials. His work involves the synthesis and characterization of semiconductor nanoparticles and their incorporation into polymer fibers and composite materials. These innovations are applied in diverse areas, including antimicrobial activity against bacteria and fungi, photocatalysis, water treatment, and the development of advanced wound dressings. His research also explores polymer fiber composites for wastewater treatment and pest repellency, highlighting the societal relevance of his work. Under his leadership, multidisciplinary research groups have investigated catalysis, adsorption, and phytochemistry, fostering innovation through collaborative projects across Africa and beyond. He has established research partnerships with universities in Kenya, contributing to knowledge exchange, student mobility, and postdoctoral mentorship. By bridging fundamental chemistry with applied science, Prof. Moloto’s research advances both theoretical understanding and real-world solutions, contributing to health, environmental sustainability, and industrial innovation in nanotechnology and materials science.

 

Publications

 

Title: Visible Light Enhanced Degradation of Sulfamethoxazole by Beta Zeolite/TiO2 Photocatalyst
Year: 2025

Title: Effect of Cellulose Acetate on the Physicochemical Properties of PVP Blended Nanofibers
Year: 2025

Title: Pelargonium alchemilloides (L). L’herit Extract–loaded Electrospun Polyvinylpyrrolidone/Cellulose Acetate Blended Nanofibers and their Antimicrobial Activity
Year: 2025

Title: Enhancing the Photocatalytic Activity of Co-precipitation Synthesized Fe3O4/ZnO Nanocomposites for Rhodamine B Degradation
Year: 2025

Title: Optimizing influential phase separation parameters on polyethersulfone/Fe3O4/ZnO membranes for environmental wastewater
Year: 202

Conclusion

Prof. Makwena Justice Moloto is a visionary scholar whose dedication to nanotechnology, chemistry, and sustainable innovation has made him a leader in scientific research, academic leadership, and international collaboration, leaving a lasting impact on education, industry, and society.

Tanyanika Phillips | Care Delivery in Thoracic Oncology | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Tanyanika Phillips | Care Delivery in Thoracic Oncology | Best Researcher Award

City of Hope National Med Center | United States

Dr. Tanyanika Phillips is an accomplished physician and academic leader specializing in thoracic and geriatric oncology. Currently serving as Assistant Professor in the Department of Medical Oncology and Therapeutics Research at City of Hope National Medical Center, she integrates patient care, research, and community health advocacy. Her professional journey reflects a steadfast dedication to improving cancer care across diverse populations, with a special focus on equity in access and outcomes. Throughout her career, she has held pivotal roles as a clinician, researcher, and administrator, contributing to health system development, rural oncology programs, and national initiatives in cancer equity. Known for her commitment to advancing inclusive research, Dr. Phillips has been instrumental in developing geriatric oncology services and clinical trials that address the needs of aging populations. Her career is distinguished by numerous leadership positions, prestigious awards, and recognition for her community-focused work in eliminating health disparities.

Profile

Scopus

Education

Dr. Tanyanika Phillips’ educational foundation reflects a balance of clinical excellence and population health. She earned her Bachelor of Science in Biology from Xavier University of Louisiana, followed by her Doctor of Medicine from the University of Rochester School of Medicine and Dentistry. Her interest in public health and health outcomes led her to pursue a Master of Public Health at Vanderbilt University, specializing in population-based studies and non-experimental design. She furthered her training through an internal medicine residency at Ochsner Clinic Foundation, a geriatric fellowship at Vanderbilt, and a prestigious medical oncology fellowship at the Sidney Kimmel Cancer Center at Johns Hopkins University. She also completed K12 Research training at Vanderbilt, emphasizing outcomes-based cancer research. Her executive education at Harvard School of Public Health and Case Western Reserve University enhanced her expertise in leadership, project management, and measurement design. This multidisciplinary academic preparation laid the groundwork for her career in oncology research, clinical innovation, and health equity.

Experience

Dr. Tanyanika Phillips has built a dynamic career across academic medicine, community oncology, and health equity leadership. She began as Assistant Professor at Case Western University, where she also directed the Health Equity Initiative in Cancer. Her dedication to accessible oncology care expanded during her tenure as a staff physician at St. John Medical Center and CHRISTUS Health, where she also served as Medical Director for Rural and Community Health. At Antelope Valley Hospital, she led the cancer program as Medical Director before joining City of Hope, where she has since shaped geriatric oncology programs, served as Site Research Champion, and directed community-focused cancer initiatives. In her current role, she balances clinical care and research, directing City of Hope’s Antelope Valley Cancer Program while advancing clinical trials in aging and thoracic oncology. Her leadership positions include Deputy Director of the Center for Cancer and Aging and Enterprise Champion for Advancing Inclusive Research.

Awards and Honors

Dr. Tanyanika Phillips’ career is marked by consistent recognition for excellence in medicine, leadership, and community service. Early in her journey, she received the Community of Caring Award from Ochsner Medical Foundation and the Futures Scholar distinction from the American Medical Directors Association. Her research potential was recognized with the American Society of Clinical Oncology Young Investigator Award. She has also been honored with a Certificate of Special Congressional Recognition for her leadership in Ohio. Her dedication to minority health and community empowerment was acknowledged through multiple awards, including the Unsung Hero Award from the North Coast Nurses Coalition and the Minority Faculty Development Award at University Hospitals Case Medical Center. At St. John Medical Center, she received Values in Action Awards for Human Dignity, Wisdom, and Presence. More recently, her contributions at City of Hope earned her the Values in Action Award for Collaboration and the 2025 Hope Colleague Award.

Research Focus

Dr. Tanyanika Phillips’ research interests are centered on thoracic oncology, geriatric oncology, and advancing equity in cancer care. She is particularly committed to designing and implementing clinical trials that address the unique needs of aging patients with cancer. Her work integrates population-based research methods, health outcomes assessment, and translational oncology to bridge gaps between laboratory advances and real-world applications. As a site research champion and program lead for geriatric oncology at City of Hope, she has facilitated community-based clinical trials aimed at improving access and participation among underrepresented populations. She is also deeply engaged in health equity research, focusing on reducing disparities in cancer outcomes through inclusive trial design and community navigation programs. Her leadership in advancing inclusive research has established her as a key figure in initiatives that integrate cancer biology, geriatrics, and population health, ensuring that scientific discoveries translate into equitable patient care.

 

Publications

 

Title: Clin-STAR Corner: Practice Changing Advances at the Interface of Oncology and Geriatrics
Year: 2025

Title: Smoking prevalence and association with sociodemographic variables in cancer clinical trial participants
Year: 2025

Conclusion

Dr. Tanyanika Phillips stands as a distinguished oncologist, educator, and leader whose career reflects an enduring commitment to patient-centered care, health equity, and translational research, integrating clinical excellence with a vision for advancing inclusive and community-driven oncology practice.

Hanan Al-Mutairi | Pediatric Oncology Nutrition | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Hanan Al-Mutairi | Pediatric Oncology Nutrition | Best Researcher Award

University of Nottingham/King Faisal Specialist Hospital | Saudi Arabia

Hanan Al-Mutairi is a dedicated senior pediatric oncology, hematology, and bone marrow transplant dietitian based in Riyadh, Saudi Arabia. With a long-standing career at King Faisal Specialist Hospital & Research Center, she has contributed significantly to advancing pediatric nutrition care in oncology settings. She began her career as a clinical dietitian at King Fahad Medical City, where she built her foundation in pediatric care. Over the years, she has become a leading figure in pediatric oncology nutrition, combining clinical expertise, research coordination, and education. She actively participates in national and international conferences, sharing insights on nutrition therapy, ketogenic diet interventions, and pediatric cancer care. Alongside her clinical responsibilities, she mentors interns, collaborates with multidisciplinary teams, and updates clinical nutrition guidelines. Through her efforts in patient education, awareness programs, and AI-driven innovations, she has emerged as a pioneer in improving nutritional outcomes for children with cancer both locally and globally.

Profile

ORCID

Education

Hanan Al-Mutairi’s academic journey reflects her dedication to pediatric oncology nutrition. She earned her bachelor’s degree in Clinical Nutrition from King Saud University, where she developed her foundation in community health and medical nutrition. Her pursuit of advanced knowledge led her to Nottingham University, UK, where she completed her master’s in Advanced Dietetics Practice with distinction, highlighting her academic excellence and clinical competence. Currently, she is a PhD candidate in Oncology at the University of Nottingham Medical School, focusing on innovative nutrition approaches in cancer therapy. In addition to her formal education, she has enriched her expertise through observerships at the Children’s Hospital of Philadelphia and SickKids Hospital in Toronto, where she gained international exposure to pediatric nutrition care. Hanan has also undertaken specialized training in metabolic nutrition, ketogenic therapies, bioinformatics, ethics, and research methodologies, complementing her academic qualifications with continuous professional development

Experience

Hanan Al-Mutairi has extensive experience spanning clinical nutrition, pediatric oncology care, and research coordination. She began her career at King Fahad Medical City as a clinical dietitian, where she gained practical expertise in pediatric nutrition. Currently, she serves as a senior pediatric oncology, hematology, and bone marrow transplant dietitian at King Faisal Specialist Hospital & Research Center, where she has worked for over a decade. Her responsibilities include conducting comprehensive nutrition assessments, interventions, and patient education in both inpatient and outpatient settings. Beyond clinical duties, she trains dietetic interns, healthcare providers, and physicians, ensuring the next generation of dietitians is well prepared. She also updates hospital nutrition policies, develops educational materials, and contributes to interdisciplinary committees. Her experience extends to coordinating nutrition research projects, establishing AI-driven patient education tools, and collaborating with national and international hospitals to advance pediatric oncology nutrition care and awareness.

Awards and Honors

Hanan Al-Mutairi has been widely recognized for her dedication to pediatric oncology nutrition through numerous awards, appreciation letters, and recognitions. She has received several commendations from directors of the King Fahad National Cancer Center for her exemplary contributions, including from Dr. Ibrahim Alghamlas, Dr. Amani Alkofidi, Dr. Abdullah AlJufri, and Dr. Alsolh. Her commitment to excellence was also acknowledged through the “Exemplary Employee” award at the Children’s Cancer Center. Beyond institutional recognition, she has been honored with appreciation letters from the Clinical Nutrition Department, Health Education Department, and patients’ families through the Patient Relation Department. Professional organizations, including SANAD society for children cancer, have also acknowledged her social and professional contributions. In addition, her role as a national and international speaker at conferences and symposiums further highlights her professional standing. These accolades reflect her commitment to advancing nutrition care, patient education, and research in pediatric oncology.

Research Focus

Hanan Al-Mutairi’s research is centered on improving nutritional outcomes for pediatric oncology patients, with a particular focus on ketogenic diet therapy in childhood brain cancers. She has contributed to studies examining the feasibility, safety, and effectiveness of ketogenic diets, while exploring oncologists’ perspectives and biochemical mechanisms underpinning dietary interventions. Her work also covers obesity, metabolic syndrome, enteral nutrition side effects, and the role of vitamin and micronutrient status in pediatric leukemia patients. She has engaged in innovative projects assessing the impact of artificial intelligence in enhancing patient and family education in oncology nutrition. Ongoing research includes investigations into picky eating in cancer survivors, enzymatic expression in brain tumors, carnitine levels in CNS tumors, and leucine supplementation in rare pediatric conditions. By combining clinical practice with translational research, she aims to integrate evidence-based nutrition therapies into pediatric cancer care, ultimately improving survival, recovery, and quality of life.

 

Publications

Title: Oncologists’ Perspectives on Ketogenic Diets in Pediatric Brain Cancer: Potential, Challenges, and the Path Forward
Year: 2025

Title: Safety, Feasibility, and Effectiveness of Ketogenic Diet in Pediatric Patients With Brain Tumors: A Systematic Review
Year: 2025

Conclusion

Hanan Al-Mutairi is a highly accomplished pediatric oncology dietitian whose career blends clinical excellence, groundbreaking research, patient-centered education, and international collaboration, making her a leading figure in advancing pediatric nutrition care and innovation.

Abdullah Mousa Khan | Ocular oncology | Excellence in Research

Published on by Cognitive Scientist Awards

Dr. Abdullah Mousa Khan | Ocular oncology | Excellence in Research

King Khaled Eye Specialsit Hospital and Research Center | Saudi Arabia

Dr. Abdullah Mousa Khan is a distinguished Saudi ophthalmologist specializing in pediatric ophthalmology and strabismus. With a career marked by clinical excellence, leadership, and academic contributions, he currently serves as Consultant II at King Khaled Eye Specialist Hospital (KKESH), Riyadh, while also holding an adjunct faculty position at Alfaisal University. Fluent in Arabic and English, Dr. Khan has established himself as a recognized leader in eye health education and surgical innovation. His professional journey spans rigorous training, international exposure, and an active role in shaping pediatric ophthalmology practices in Saudi Arabia and beyond. As Fellowship Program Director at KKESH, he plays a vital role in mentoring future ophthalmologists. He is also engaged in scientific publishing, peer-reviewed research, and conference presentations worldwide. Known for his dedication to patient-centered care and medical education, Dr. Khan embodies the integration of advanced clinical practice, academic excellence, and community service in ophthalmology.

Profile

Google scholar

Education

Dr. Abdullah Mousa Khan’s academic foundation began with outstanding achievements during his early schooling in Taif, followed by a Bachelor of Medicine and Surgery from King Saud University, where he graduated with first-class honors. His strong performance set the stage for his residency training in ophthalmology at King Khaled Eye Specialist Hospital, one of the leading centers in the region. Pursuing advanced specialization, he completed a fellowship in pediatric ophthalmology and strabismus at KKESH, further refining his expertise in managing complex pediatric and strabismus cases. Alongside his formal qualifications, Dr. Khan successfully cleared a series of prestigious examinations, including the Saudi Board, Jordanian Board, International Council of Ophthalmology assessments, and licensing requirements across Saudi Arabia and internationally. His pursuit of continuous professional growth is marked by memberships and fellowships from respected institutions, including the Royal College of Surgeons of Edinburgh and the International Council of Ophthalmology, reflecting both depth and breadth in his education.

Experience

Dr. Abdullah Mousa Khan has developed an impressive portfolio of clinical, academic, and leadership experience. He currently serves as Consultant II in Pediatric Ophthalmology and Strabismus at King Khaled Eye Specialist Hospital, where he also directs the fellowship program, shaping future specialists in this field. In parallel, he contributes to medical education as an Adjunct Assistant Professor at Alfaisal University, guiding undergraduate and postgraduate medical students. His experience extends internationally, having completed observerships and training in leading institutions in the United States, India, South Korea, and Saudi Arabia, gaining exposure to diverse practices in ophthalmology. Over the years, he has held key leadership roles, including chief fellow and chief resident, which strengthened his ability to coordinate clinical teams and training programs. In addition to his clinical duties, Dr. Khan actively engages in research, conference presentations, and editorial work, reinforcing his multidimensional role as a physician, educator, and academic leader.

Awards and Honors

Dr. Abdullah Mousa Khan’s excellence has been recognized through multiple awards and honors at different stages of his career. His early dedication earned him first-class honors upon completing his MBBS at King Saud University. He demonstrated academic and leadership distinction through student competitions, where he won prizes for innovation, teamwork, and presentation skills. During his residency and professional journey, he received accolades for research and scientific presentations, notably winning the Best Poster Presentation Award at the Saudi Ophthalmology Conference for his work on penetrating keratoplasty outcomes. These achievements highlight his ability to merge clinical practice with research innovation. He has also earned prestigious memberships and fellowships, including the FICO and FRCSEd (Ophth), which underscore his international recognition. His progression from medical school awards to international certifications illustrates his consistent pursuit of excellence and reflects a career dedicated to advancing ophthalmology through both practice and academic contributions.

Research Focus

Dr. Abdullah Mousa Khan’s research is centered on pediatric ophthalmology, strabismus, and complex glaucoma in children. His work emphasizes surgical innovations, comparative outcomes of glaucoma drainage devices, and novel approaches for improving visual prognosis in pediatric patients. He has published extensively in peer-reviewed journals, contributing valuable insights into the long-term outcomes of pediatric glaucoma surgeries, management of strabismus, and unique case reports involving rare ocular conditions. His research portfolio also includes studies on ocular infections, thyroid eye disease, panuveitis, and complications in cataract surgery, highlighting his broad investigative interests. Through clinical trials, case studies, and collaborative works, Dr. Khan bridges clinical challenges with academic inquiry, aiming to enhance surgical outcomes and patient care. He is also active in delivering presentations at international and regional conferences, disseminating findings that advance knowledge and clinical practices. His research ultimately reflects a commitment to innovation and evidence-based pediatric ophthalmology.

 

Publications

Title: Analysis of retinal structure and function in cone dystrophy with supernormal rod response
Year: 2020
Citation: 10

Title: The use of one muscle recession for horizontal strabismus
Year: 2018
Citation: 8

Title: Risk factors, complications, and outcomes of phacoemulsification cataract surgery complicated by retained lens fragments in Asian eyes: A 10-year retrospective study
Year: 2022
Citation: 6

Title: Manifestation of panuveitis after intraocular surgery in a child with blau syndrome
Year: 2021
Citation: 1

Conclusion

Dr. Abdullah Mousa Khan is a distinguished ophthalmologist whose journey reflects a blend of academic brilliance, clinical excellence, leadership, research innovation, and community service, making him a leading figure in pediatric ophthalmology and strabismus in Saudi Arabia and beyond.

Amit Kumar Yadav | Biosensors and Point-of-Care Devices | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Amit Kumar Yadav | Biosensors and Point-of-Care Devices | Best Researcher Award

Indian Institute of Technology Gandhinagar (IITGn) | India

Dr. Amit Kumar Yadav, Ph.D. (PMRF, AMRSC), is an accomplished researcher specializing in electrochemistry, nanomaterials engineering, DNA nanotechnology, conducting hydrogels, and biosensor development. Currently serving as an Early Career Fellow at the Department of Biological Sciences and Engineering, Indian Institute of Technology Gandhinagar (IIT-Gn), he focuses on developing DNA aptamer-based biosensing platforms for diagnostic applications. His research integrates nanobiotechnology, functional nanomaterials, and molecular biology to design innovative biosensors for early disease detection and therapeutic monitoring. Dr. Yadav’s academic and professional journey spans premier Indian institutions, where he has contributed to projects on cancer biomarkers, bacterial resistance, and cytokine detection. His commitment to translational nanotechnology research is reflected in numerous awards, including multiple Young Scientist Awards and recognition for his Ph.D. thesis. With a vision to advance healthcare diagnostics, Dr. Yadav aspires to pursue impactful postdoctoral research that bridges laboratory innovation with real-world medical applications.

Profile

Googlescholar

Education

Dr. Amit Kumar Yadav pursued his Ph.D. in Nanoscience at Jawaharlal Nehru University, where his doctoral work focused on fabricating electrochemical nanodiagnostic platforms for detecting cancer biomarkers. Guided by Prof. Partima Solanki, his research emphasized translational nanotechnology for biomedical applications. He obtained his Master of Science in Biotechnology from Vinoba Bhave University, where his thesis explored the antimicrobial properties of bioactive peptides under Prof. Kanwaljeet Kaur’s supervision. Earlier, he completed his Bachelor of Science in Biotechnology at St. Columba’s College, Vinoba Bhave University, where he built a strong foundation in molecular biology and bioengineering under Dr. Gautam Kumar. His academic journey began with strong performance in science at Inter Science College, Jharkhand Academic Council, followed by secondary education at High School Bishnugarh. His education reflects a steady progression from fundamental biotechnology to advanced nanobiotechnology and biosensor development, enabling him to integrate multidisciplinary insights into applied healthcare research

Experience

Dr. Amit Kumar Yadav has diverse academic and industrial research experience across leading Indian institutes. Currently an Early-Career Fellow at IIT Gandhinagar under Prof. Dhiraj Bhatia, he is working on the development of DNA aptamers for cytokine biosensing. Alongside, he serves as a Senior Scientist at QnanoSol BioTech, driving translational biosensor technologies. Prior to this, he worked as Research Associate at IIT Gandhinagar, contributing to nano-bioengineering projects. During his Ph.D. as a Prime Minister’s Research Fellow at Jawaharlal Nehru University, he developed aptasensors for gastric cancer biomarker detection and electrochemical diagnostic platforms. He also contributed as a Junior Research Fellow at JNU and the University of Delhi, studying cancer drug resistance and bacterial resistance mechanisms. His early training included thesis research at the National Institute of Immunology and a summer fellowship at Delhi Technological University. Collectively, his experience highlights innovation in nanobiotechnology, biosensing, and diagnostic device development.

Awards and Honors

Dr. Amit Kumar Yadav’s scientific excellence has been recognized through multiple national and international honors. He received the Young Scientist Award at the International Conference on Viksit Bharat 2047: Reaching the Unreached Through Chemical and Biological Sciences, acknowledging his contributions to nanobiotechnology and biosensors. His impactful research in cancer diagnostics earned him another Young Scientist Award at Parul University’s National Conference on Cancer Research and Therapy. He was also honored with the Young Scientist Award at the National Conference on Cancer Biology, Institute of Advanced Research, Gandhinagar, for pioneering biosensor advancements. In addition, his doctoral work received the Outstanding Ph.D. Thesis Award from the Society for Biomaterials and Artificial Organs-India, marking his innovative approach to electrochemical nanodiagnostics. His international recognition includes the ICMR International Travel Grant Support Award, enabling global exposure and collaboration. These accolades reflect his commitment to pushing scientific frontiers and addressing global healthcare challenges through nanotechnology-driven solutions.

Research Focus

Dr. Amit Kumar Yadav’s research lies at the intersection of nanobiotechnology, electrochemistry, and translational diagnostics. His primary focus is on developing nano-biosensors for early disease detection, particularly aptamer-based and DNA nanostructure-enabled biosensing platforms. His expertise includes designing electrochemical aptasensors for cancer biomarkers, fabricating conducting hydrogels for biosensing applications, and engineering functional nanomaterials for enhanced sensitivity. He has extensively worked with tetrahedral DNA nanostructures (TDNs), antibody-aptamer recognition systems, and SELEX-driven aptamer selection, enabling specific and reliable biomolecule detection. Beyond cancer diagnostics, his research explores antimicrobial resistance monitoring, food toxin detection, and cytokine sensing for immunological applications. He also investigates two-dimensional materials, nano-bioengineering, and material sciences for cross-disciplinary applications in healthcare and biotechnology. His vision is to bridge laboratory-scale innovations with real-world clinical use by creating low-cost, highly sensitive, and portable diagnostic tools that can significantly impact early-stage disease management and global public health.

 

Publications

 

Title: Emerging role of trimethylamine-N-oxide (TMAO) in colorectal cancer
Year: 2021
Citation: 291

Title: Internet of things (IoT) in nano-integrated wearable biosensor devices for healthcare applications
Year: 2022
Citation: 273

Title: FRET based biosensor: principle applications recent advances and challenges
Year: 2023
Citation: 118

Title: Strategies and perspectives to develop SARS-CoV-2 detection methods and diagnostics
Year: 2020
Citation: 115

Title: Gut microbiota-derived metabolites in CRC progression and causation
Year: 2021
Citation: 98

Title: Gut microbiota derived trimethylamine N-oxide (TMAO) detection through molecularly imprinted polymer based sensor
Year: 2021
Citation: 85

Title: A highly sensitive label-free amperometric biosensor for norfloxacin detection based on chitosan-yttria nanocomposite
Year: 2020
Citation: 84

Conclusion

Dr. Amit Kumar Yadav is a dynamic early-career researcher whose expertise in nanobiotechnology, biosensors, and electrochemical diagnostics reflects a deep commitment to advancing low-cost, sensitive, and translational healthcare technologies for early disease detection and global health improvement.

Tianle Gao | Antifungal Medicine | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Tianle Gao | Antifungal Medicine | Best Researcher Award

Chinese Academy of Medical Sciences and Peking Union Medical College | China

Tianle Gao is a distinguished pharmacology researcher from the People’s Republic of China, serving as an Associate Researcher at the Institute of Materia Medica, Chinese Academy of Medical Sciences. With advanced training in pharmacology and neuropharmacology at globally renowned institutions in Sweden, Dr. Gao has established a strong research profile in the fields of drug discovery and medicinal sciences. He actively contributes to scientific development through his editorial roles in leading pharmaceutical journals and his service as a youth member of the Pharmaceutical Affairs Management Committee of the Chinese Pharmaceutical Association. His research integrates pharmacological principles with translational approaches to address unmet medical needs. Dedicated to advancing medicinal biotechnology and pharmacological innovation, Dr. Gao is recognized for his scholarly contributions, leadership in scientific communities, and commitment to fostering the next generation of researchers. His multidisciplinary expertise reflects a global vision combined with national dedication to healthcare advancement.

Profile

Scopus

Education

Tianle Gao pursued his doctoral studies in pharmacology at the prestigious Karolinska Institute in Sweden, where he developed a deep foundation in pharmacological mechanisms and therapeutic development. His academic journey emphasized experimental pharmacology, molecular biology, and the study of drug action in complex biological systems. Following this, he expanded his academic experience through postdoctoral training at Uppsala University BMC in Sweden, where he specialized in neuropharmacology research. This stage of his education provided him with expertise in neurochemical processes, signaling pathways, and the pharmacological basis of neurological disorders. His academic training combines international exposure with rigorous scientific inquiry, enabling him to bridge fundamental pharmacology with applied medicinal sciences. By engaging with multidisciplinary perspectives and collaborating across borders, Dr. Gao has cultivated a comprehensive understanding of drug development, neuropharmacology, and translational medicine. His educational background continues to inform his research, shaping his innovative approach to advancing pharmacological and therapeutic sciences.

Experience

With a career shaped by global academic training and national scientific service, Tianle Gao currently holds the position of Associate Researcher at the Institute of Materia Medica, Chinese Academy of Medical Sciences. His role emphasizes pharmacological research and development, particularly in advancing medicinal biotechnology and therapeutic solutions. Beyond his institutional appointment, he contributes significantly to the broader pharmaceutical community through active service in professional organizations. As a youth member of the Pharmaceutical Affairs Management Committee of the Chinese Pharmaceutical Association, he participates in shaping research agendas and pharmaceutical policies. His editorial responsibilities with leading journals such as China Medicinal Biotechnology, Acta Pharmaceutica Sinica, and Acta Pharmaceutica Sinica B highlight his dedication to scholarly dissemination and peer mentorship. His professional journey reflects a balance of laboratory research, academic publishing, and scientific leadership. Through these combined experiences, he plays a critical role in strengthening pharmacological sciences both nationally and internationally.

Awards and Honors

Tianle Gao has received recognition for his excellence in research, leadership, and contributions to pharmacology and medicinal sciences. His academic achievements and service in professional organizations have earned him respect as a promising scholar and emerging leader. He has been honored with distinctions such as the Distinguished Scientist Award, Young Scientist Award, and Best Researcher Award, reflecting his commitment to advancing pharmacological knowledge. In recognition of his innovative research, he has also been awarded the Best Innovation Award and Excellence in Research honors. His involvement as a youth editorial board member of highly respected journals further underscores his scholarly reputation. These recognitions serve as a testament to his sustained contributions to pharmacological science and his efforts to mentor young researchers. Through these honors, Dr. Gao continues to be acknowledged as a researcher who bridges global academic training with national scientific advancement.

Research Focus

Tianle Gao’s research is centered on pharmacology, neuropharmacology, and medicinal biotechnology, with a strong emphasis on translating scientific discoveries into therapeutic solutions. His work explores the molecular mechanisms of drug action, the pharmacological pathways underlying neurological disorders, and innovative strategies for drug discovery and development. By integrating basic pharmacological research with applied medicinal studies, he contributes to the advancement of treatments for complex diseases. His focus also includes the exploration of bioactive compounds, pharmacokinetics, and safety evaluations, ensuring that research outcomes can progress toward clinical application. His participation in major research projects, publication of scholarly articles, and contributions to scientific committees reflect his dedication to advancing global knowledge in pharmacology. Through international collaborations and editorial leadership, he promotes the dissemination of high-quality research. His research philosophy combines innovation with translational impact, aiming to address healthcare challenges and improve therapeutic strategies for human well-being.

 

Publications

 

Title: Isochlorogenic Acid C Alleviates Allergic Asthma via Interactions Between Its Bioactive Form and the Gut Microbiome
Year: 2025

Title: Exploring the transcriptome of resident spinal microglia after collagen antibody-induced arthritis
Year: 2019

Title: Sinomenine facilitates the efficacy of gabapentin or ligustrazine hydrochloride in animal models of neuropathic pain
Year: 2019

Title: The Neuropeptide Y System Regulates Both Mechanical and Histaminergic Itch
Year: 2018

Conclusion

Tianle Gao is a globally trained pharmacology researcher whose expertise, experience, and recognized contributions in drug discovery, neuropharmacology, and medicinal biotechnology continue to strengthen pharmaceutical sciences and inspire innovation in healthcare advancement.